(Q43037979)

12 November 2017

Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method (English)

1 reference

12 November 2017

1 reference

1 reference

Jean-Michel Pawlotsky

4

1 reference

12 November 2017

2

Magali Bouvier-Alias

0 references

author name string

Stéphane Chevaliez

1

1 reference

12 November 2017

Magali Bouvier-Alias

2

1 reference

12 November 2017

Rozenn Brillet

3

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

12 November 2017

1 reference

12 November 2017

46

1 reference

12 November 2017

1

1 reference

12 November 2017

22-31

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

12 November 2017

1 reference

Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

7 January 2021

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

7 January 2021

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

7 January 2021

Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin

1 reference

7 January 2021

Therapy of hepatitis C: from empiricism to eradication

1 reference

7 January 2021

Molecular diagnosis of viral hepatitis

1 reference

7 January 2021

Use of virologic assays in the diagnosis and management of hepatitis C virus infection

1 reference

7 January 2021

Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay

1 reference

7 January 2021

Comparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in Serum

1 reference

7 January 2021

Strengths and limitations of commercial tests for hepatitis C virus RNA quantification

1 reference

7 January 2021

Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow.

1 reference

7 January 2021

Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)

1 reference

7 January 2021

Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA

1 reference

7 January 2021

Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum

1 reference

7 January 2021

Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.

1 reference

7 January 2021

Multilaboratory Comparison of Hepatitis C Virus Viral Load Assays

1 reference

7 January 2021

Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument

1 reference

7 January 2021

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays

1 reference

7 January 2021

Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5

1 reference

7 January 2021

A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21656

1 reference

12 November 2017

1 reference